Tandem Diabetes Care (TNDM) Cost of Revenue (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Cost of Revenue came in at $110.4 million in Q1 2026, down 4.81% YoY from $116.0 million in Q1 2025, and down 10.16% on a QoQ basis from $122.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Cost of Revenue (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Cost of Revenue data on file, last reported at $110.4 million in Q1 2026.
- Quarterly Cost of Revenue fell 4.81% year-over-year to $110.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $463.1 million (down 1.38% YoY) and the FY2025 annual result came in at $468.7 million, up 4.02% from the prior year.
- Cost of Revenue retreated to $110.4 million in Q1 2026, from $122.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $125.2 million in Q4 2024 to a low of $84.8 million in Q1 2022.
- A 5-year average of $105.8 million and a median of $105.0 million in 2022 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue increased 25.19% — and 2026, when it declined 4.81%.
- Tracing TNDM's Cost of Revenue over 5 years: stood at $105.0 million in 2022, then fell by 1.41% to $103.5 million in 2023, then rose by 20.96% to $125.2 million in 2024, then dropped by 1.81% to $122.9 million in 2025, then slipped by 10.16% to $110.4 million in 2026.
- The last three Cost of Revenue figures came in at $110.4 million (Q1 2026), $122.9 million (Q4 2025), and $115.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Tandem Diabetes Care | 1.58 Bn | 1.12 Bn | 144.78 Mn | 109.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.78 Mn |
| Jun 30, 2026 | 109.78 Mn |
| Mar 31, 2026 | 110.43 Mn |
| Mar 31, 2026 | 110.43 Mn |
| Dec 31, 2025 | 122.92 Mn |
| Dec 31, 2025 | 122.92 Mn |
| Sep 30, 2025 | 114.96 Mn |
| Sep 30, 2025 | 114.96 Mn |
| Jun 30, 2025 | 114.82 Mn |
| Jun 30, 2025 | 114.82 Mn |
| Mar 31, 2025 | 116.02 Mn |
| Mar 31, 2025 | 116.02 Mn |
| Dec 31, 2024 | 125.19 Mn |
| Dec 31, 2024 | 125.19 Mn |
| Sep 30, 2024 | 119.32 Mn |
| Sep 30, 2024 | 119.32 Mn |
| Jun 30, 2024 | 109.12 Mn |
| Jun 30, 2024 | 109.12 Mn |
| Mar 31, 2024 | 97.00 Mn |
| Mar 31, 2024 | 97.00 Mn |